to triglycerides) takes place primarily in the liver of birds and involves in a series of linked, enzymecatalyzed reactions including glycolysis, the citric acid cycle and fatty acid synthesis. Hepatic lipogenesis is subjected to both the nutritional and hormonal control and this metabolic process is highly responsive to changes in the diet (Hillgartner et al., 1995; Kersten, 2001) . The nutritional state of the bird, as determined by the amount and composition of feed consumed, dramatically affects the hepatic lipid metabolism (Hillgartner et al., 1995) .
Dihydropyridine is a new multifunctional antioxidant in food (Kouřimská et al., 1993; Smagin, 1998; Tirzitis and Kirule, 1999; Pánek et al., 2000; Tirzitis et al., 2001) . It has been shown that dihydropyridine has the antioxidant and immunological activity in ducks (Bakutis and Bukis, 1984) and chickens (Valdman et al., 1990) . Dihydropyridine improved the health of cows, improved the quality of milk, and increased cow fertility (Sutkevicius et al., 1984) . It also reduced the body weight loss in young fattened cattle during transport to the meat-packing plant (Spruzh and Igaune, 1991) . Dihydropyridine also regulated the lipid metabolism in humans (Zhang et al., 2002) . The study indicated that dihydropyridine could improve the laying performance and decrease hepatic fat and abdominal fat in laying hens (Zou et al., 2007) . Furthermore, dihydropyridine, as a calcium channel blocker or calcium antagonist, is the effective drug in curing cardiovascular diseases in humans, including angina, hypertension, myocardial ischemia, cardiac failure and atherosclerosis (Luft and Haller, 1993; Zhang, 1996) . However, there is no report on the regulation of lipid metabolism by dihydropyridine in broiler chickens. The objective of this study is to evaluate the effects of dietary dihydropyridine supplementation on growth performance and lipid metabolism of broilers to provide the clue for developing a new kind of feed additive which could effectively reduce the fat deposition in broilers.
MATERIAL AND METHODS

Experimental design and birds
This experiment was conducted according to protocols approved by the Northwest A and F University Animal Care and Use Committee. A total of 480 one-day-old female Arbor Acres broiler chicks were obtained from a local hatchery and randomly divided into four groups, each group had six replications, and each replication 20 birds. The birds were fed maize-soybean meal basal diet supplemented with 0, 100, 200, or 300 mg/kg dihydropyridine, respectively. The dihydropyridine was provided by Sunpu Biochem. Tech. Co., Ltd, Beijing, China. Feed and water were provided ad libitum. The photoperiod was set at 22L:2D throughout the whole experimental period. The room temperature was at 35°C at the first day and gradually reduced to 25°C by the end of the third week.
At the end of the experiment, two birds from each replication were killed after 12 h fasting and ad libitum access to water. Abdominal fat pad and liver weight were determined.
Blood samples were obtained via the vena cava puncture. The serum was transferred into an Eppendorf centrifuge tube (10 ml), centrifuged for 10 min, and then kept at -30°C for analysis.
Experimental parameters measured
Hepatic fat percentage: Liver samples were homogenized and dried to constant weight at 105°C. A dried sample (2 g) was extracted with a chloroform: ether mixture (5:1) in a Soxhlet apparatus for 8 h, and the extracted sample was dried to constant weight at 105°C. Fat weight was calculated by subtracting the sample weight after extraction from the sample weight before extraction and hepatic fat percentage as: fat weight/dried liver weight × 100%.
SOD activity, apoA, apoB and MDA content in liver: The liver tissue was homogenized with 0.9% sodium chloride solution to make a 10% hepatic mixture, which was then centrifugated at 2 000 g for 10-15 min, the upper pellucid liquid was taken for parameter determination. The SOD activity was determined by colorimetry according to the assay kit provided by Nanjing Jiancheng Bioengineering Institute. ApoA, apoB and MDA contents were determined with a UV-2000 spectrophotometer (UNICO Instruments Co., Ltd., Shanghai, China) using analysis kits provided by Ningbo City Biochemical Reagent Factory and Nanjing Jiancheng Bioengineering Institute, China.
Biochemical parameters related to fat metabolism: Serum triglycerides (TG), cholesterol, high density lipoprotein-cholesterol (HDL-C), and very low density lipoprotein-cholesterol (VLDL-C) were measured with an ERBA CHEM-5 semi-automatic biochemical analyzer using analysis kits provided by Ningbo City Bio-chemical Reagent Factory, China.
HSL activity was measured using the method reported by Shih et al. (1995) . The fat was minced and homogenized in 10 volumes of pH 7.0 medium containing 0.25M sucrose, 1mM EDTA, 4 μg/ml leupeptin, 1 μg/ml pepstatin A, and 1mM dithiothreitol, then centrifuged at 105 000 g for 45 min at 4°C. The superficial fat cake was removed and the clear supernatant decanted and used for the assay of HSL activity based on the standard assay procedure of Nilsson-Ehle and Schotz. The assay substrate was prepared immediately before use to give a final concentration of each reagent in the 200 μl assay volume as follows: 100 mmol/l Tris HCl, pH 7.0; 5 g/l of BSA (fatty acid-free, fraction V), and 4.58 mmol/l triolein as substrate. A unit of HSL activity was defined as: one HSL activity unit is the concentration of enzyme that hydrolyzes 1 µmol olive oil in one minute at 37°C.
The activity of glucose-6-phosphate dehydrogenase (G-6-PDH), malic dehydrogenase (MDH), isocitrate dehydrogenase (ICD) in liver, and lipoprotein lipase (LPL) in abdominal fat were determined as reported before (Xu et al., 2003) .
Hormone concentrations: Concentrations of triiodothyronine (T 3 ), thyroxine (T 4 ) and insulin in serum were measured using an RIA kit (Beijing North Immunological Institute, China) and a gamma-counter (Packard 8500, USA).
Statistical analysis: All the data were analyzed statistically using the general linear model procedure (SAS Institute, 1989 ) and the treatment means were separated by Duncan's multiple range test (P = 0.05).
RESULTS
Body weight at 42 days, feed intake, feed/gain, abdominal fat and liver fat are shown in Table 2 . respectively. There were no significant differences in feed efficiency, abdominal fat percentage and liver fat percentage among 100, 200, and 300 mg/kg dietary dihydropyridine (P < 0.05). No significant differences were observed in body weight and feed intake (P > 0.05).
The activities of enzymes related to lipid metabolism are shown in Table 3 . 100 mg/kg dihydropyridine had no effect on HSL activity in liver or abdominal fat, while a higher level of dietary dihydropyridine supplementation (200 or 300 mg/kg) increased the HSL activity (P < 0.05). The LPL activity in abdominal fat was significantly decreased by dihydropyridine (P < 0.05). The activity of G-6-PDH and MDH in liver was significantly decreased, whereas the ICD activity in liver was not significantly affected by dietary dihydropyridine.
There were significant effects of dietary dihydropyridine on cAMP, SOD, and MDA (P < 0.05, Table 3 ), content of cAMP was increased (P < 0.05), dehydrogenase; G-6-PDH = glucose-6-phosphate dehydrogenase; SOD = superoxide dismutase; MDA = malondialdehyde SOD activity was increased (P < 0.05), and MDA content was decreased (P < 0.05) 100 and 200 mg per kg dihydropyridine increased ApoB (P < 0.05, Table 4 ), but 300 mg/kg dihydropyridine had no effect on ApoB compared with the control group. T3 was significantly increased by dietary dihydropyridine (P < 0.05). There were no differences in ApoA, cholesterol, TG, HDL-C, VLDL-C, T4, and insulin among dietary treatments.
DISCUSSION
The results of this study demonstrated that supplements of dihydropyridine could significantly improve feed efficiency and reduce fat deposition in broiler chickens. This is similar to the results reported by Chen et al. (1993) and Zou et al. (1999 Zou et al. ( , 2007 in laying hens.
Lipogenic and lipolytic enzymes in liver and abdominal fat were determined to investigate the effect of dihydropyridine on lipid metabolism. MDH, ICD and G-6-PDH are responsible for generating NADPH for the support of lipogenesis while hormone-sensitive lipase has the opposite effect of mobilizing fatty acids from adipocytes into the blood stream in the process of lipolysis. Lipoprotein lipase in adipose tissue is involved in the movement of fatty acids from TG in blood chylomicrons and VLDL to the adipocytes (Gondret and Lebret, 2002; Xu et al., 2003; Kokta and Dodson, 2004; Pashkov et al., 2005) . At 42 days of age, the activities of NADPHgenerating enzymes were significantly decreased in liver and abdominal fat by dietary dihydropyridine, whereas HSL was significantly increased. It is evident that changes in the deposition of liver and abdominal fat are closely associated with patterns of HSL and NADPH-generating enzymes. The enzymatic machinery of liver and adipose tissue has adapted in such a way as to increase or decrease the capacity for NADPH generating for fatty acid synthesis and mobilization of fatty acids from adipose tissue, thereby facilitating the use of energy toward the maintenance and growth process (Diaz et al., 1999; Lien and Jan, 1999) .
The present study demonstrated that dihydropyridine significantly increased the SOD activity of serum and liver in broilers and significantly decreased MDA content in liver. This observation is similar to the results of Sniedze et al. (1977) , who showed that dihydropyridine had an antioxidant function in animals and reduced the oxidation of lipid compounds. SOD protects important organs from the attack by free radicals and maintains their normal physiological function by disposing of excessive free radicals. Paradis et al. (1997) reported that dihydropyridine combined with terminal oxidase cytochrome p450 to form a complex which HDL-C = high density lipoprotein-cholesterol; T 3 = triiodothyronine; T 4 = thyroxine significantly restrained the activity of NADPH-cytochrome reductase, restrained NADPH production and then reduced lipid superoxidation.
Results of this study also showed that dihydropyridine significantly improved the level of apolipoprotein B in liver. ApoB 100 is a major component of VLDL, which transports triglycerides out of liver. Yin et al. (2000) showed by immune electron microscopy that fat was joined to the apoB chain to form VLDL, which then transports endogenous fat to extrahepatic tissues.
The present results demonstrated that dihydropyridine increased the T 3 level in serum and simultaneously decreased the insulin level, which agrees with observations of Wu et al. (1999) in pigs. T 3 plays an important role in regulating the protein and lipid metabolism. An increase in T 3 concentration could increase fat mobilization and hydrolysis, and insulin has the reverse effects. Valcavi et al. (1997) and Tashi et al. (1998) found that there was a positive correlation between thyroxine and leptin levels and that thyroxine stimulated the secretion of leptin. Leptin is a protein secreted by adipocytes which maintains the relative stability of body fat by regulating the energy metabolism. Leptin absence will induce an increased insulin level in serum and stimulate hepatic fatty acid synthesis, as already shown in mice with leptin absence. In mice whose leptin receptor genes were knocked-out, symptoms of insulin resistance and fatty liver were still present even if the serum leptin level increased. So it is speculated that dihydropyridine can regulate the fat metabolism of laying hens through regulating the secretion of leptin in adipocytes.
In conclusion, the present research indicated that dietary dihydropyridine could improve feed efficiency and decrease hepatic fat percentage and abdominal fat percentage by affecting the fat metabolism in broilers. 200 mg/kg dihydropyridine is the optimum dose.
